Edvinsson L, Haanes KA, Warfvinge K, Krause DN (2018) CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol 14(6):338–350. https://doi.org/10.1038/s41582-018-0003-1

Article  CAS  PubMed  Google Scholar 

Karsan N, Edvinsson L, Vecsei L, Goadsby PJ (2024) Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders. Ann Clin Transl Neurol 11(7):1654–1668. https://doi.org/10.1002/acn3.52119

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tuka B, Helyes Z, Markovics A, Bagoly T, Németh J, Márk L et al (2012) Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system. Peptides 33(2):307–316. https://doi.org/10.1016/j.peptides.2011.12.019

Article  CAS  PubMed  Google Scholar 

Körtési T, Tuka B, Tajti J, Bagoly T, Fülöp F, Helyes Z et al (2018) Kynurenic acid inhibits the electrical stimulation induced elevated pituitary adenylate cyclase-activating polypeptide expression in the TNC. Front Neurol 8:745. https://doi.org/10.3389/fneur.2017.00745

Article  PubMed  PubMed Central  Google Scholar 

Pellesi L, Ashina M, Martelletti P (2024) Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention. Expert Opin Emerg Drugs 29(1):57–64. https://doi.org/10.1080/14728214.2024.2317778

Article  CAS  PubMed  Google Scholar 

Ashina M, Phul R, Khodaie M, Löf E, Florea I (2024) A monoclonal antibody to PACAP for Migraine Prevention. N Engl J Med 391(9):800–809. https://doi.org/10.1056/NEJMoa2314577

Article  CAS  PubMed  Google Scholar 

Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J (1985) Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 62(1):131–136. https://doi.org/10.1016/0304-3940(85)90296-4

Article  CAS  PubMed  Google Scholar 

Edvinsson L, McCulloch J, Uddman R (1981) Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. J Physiol 318:251–258. https://doi.org/10.1113/jphysiol.1981.sp013862

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edvinsson JC, Reducha PV, Sheykhzade M, Warfvinge K, Haanes KA, Edvinsson L (2021) Neurokinins and their receptors in the rat trigeminal system: Differential localization and release with implications for migraine pain. Mol Pain 17:17448069211059400. https://doi.org/10.1177/17448069211059400

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moskowitz MA (1993) Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43(6 Suppl 3):S16–S20

CAS  PubMed  Google Scholar 

Neubert JK, Maidment NT, Matsuka Y, Adelson DW, Kruger L, Spigelman I (2000) Inflammation-induced changes in primary afferent-evoked release of substance P within trigeminal ganglia in vivo. Brain Res 871(2):181–191. https://doi.org/10.1016/s0006-8993(00)02440-9

Article  CAS  PubMed  Google Scholar 

Goldstein DJ, Wang O, Saper JR, Stoltz R, Silberstein SD, Mathew NT (1997) Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia 17(7):785–790. https://doi.org/10.1046/j.1468-2982.1997.1707785.x

Article  CAS  PubMed  Google Scholar 

Diener HC, RPR100893 Study Group (2003) RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia 23(3):183–185. https://doi.org/10.1046/j.1468-2982.2003.00496.x

Article  PubMed  Google Scholar 

Olesen J (2024) Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives - a narrative review. J Headache Pain 25(1):105. https://doi.org/10.1186/s10194-024-01796-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Headache Classification Committee of the International Headache Society (IHS) (2018) The International classification of Headache disorders, 3rd edition. Cephalalgia 38(1):1–211. https://doi.org/10.1177/0333102417738202

Ashina M, Hansen JM, Á Dunga BO, Olesen J (2017) Human models of migraine - short-term pain for long-term gain. Nat Rev Neurol 13(12):713–724

Article  PubMed  Google Scholar 

Miettinen OS (1968) The matched pairs design in the case of all-or-none responses. Biometrics 24(2):339–352

Article  CAS  PubMed  Google Scholar 

Schaffalitzky De Muckadell S OB, Aggestrup, Stentoft P (1986) Flushing and plasma substance P concentration during infusion of synthetic substance P in normal man. Scand J Gastroenterol 21(4):498–502. https://doi.org/10.3109/00365528609015169

Article  Google Scholar 

Ashina M, Terwindt GM, Al-Karagholi MA, de Boer I, Lee MJ, Hay DL et al (2021) Migraine: disease characterisation, biomarkers, and precision medicine. Lancet 397(10283):1496–1504. https://doi.org/10.1016/S0140-6736(20)32162-0

Article  CAS  PubMed  Google Scholar 

Al-Hassany L, Boucherie DM, Creeney H, van Drie RWA, Farham F, Favaretto S et al (2023) Future targets for migraine treatment beyond CGRP. J Headache Pain 24(1):76. https://doi.org/10.1186/s10194-023-01567-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uddman R, Edvinsson L (1989) Neuropeptides in the cerebral circulation. Cerebrovasc Brain Metab Rev 1(3):230–252

CAS  PubMed  Google Scholar 

Fusco BM, Barzoi G, Agrò F (2003) Repeated intranasal capsaicin applications to treat chronic migraine. Br J Anaesth 90(6):812. https://doi.org/10.1093/bja/aeg572

Article  CAS  PubMed  Google Scholar 

Ashina H, Christensen RH, Hay DL, Pradhan AA, Hoffmann J, Reglodi D et al (2024) Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine. Nat Rev Neurol 20(11):660–670. https://doi.org/10.1038/s41582-024-01011-4

Article  PubMed  Google Scholar 

Dionne RA, Max MB, Gordon SM, Parada S, Sang C, Gracely RH et al (1998) The substance P receptor antagonist CP-99,994 reduces acute postoperative pain. Clin Pharmacol Ther 64(5):562–568. https://doi.org/10.1016/S0009-9236(98)90140-0

Article  CAS  PubMed  Google Scholar 

Sindrup SH, Graf A, Sfikas N (2006) The NK1-receptor antagonist TKA731 in painful diabetic neuropathy: a randomised, controlled trial. Eur J Pain 10(6):567–571. https://doi.org/10.1016/j.ejpain.2005.08.001

Article  CAS  PubMed  Google Scholar 

Vollesen AL, Benemei S, Cortese F, Labastida-Ramírez A, Marchese F, Pellesi L et al (2018) Migraine and cluster headache - the common link. J Headache Pain 19(1):89. https://doi.org/10.1186/s10194-018-0909-4

Article  PubMed  PubMed Central  Google Scholar 

Ohanyan T, Schoepke N, Eirefelt S, Hoey G, Koopmann W, Hawro T et al (2018) Role of Substance P and its receptor neurokinin 1 in chronic Prurigo: a Randomized, Proof-of-Concept, controlled trial with topical aprepitant. Acta Derm Venereol 98(1):26–31. https://doi.org/10.2340/00015555-2780

Article  CAS  PubMed  Google Scholar